Agilent Technologies, Inc. (A)
NYSE: A · Real-Time Price · USD
151.25
+6.19 (4.27%)
At close: Nov 21, 2025, 4:00 PM EST
151.90
+0.65 (0.43%)
After-hours: Nov 21, 2025, 7:59 PM EST
Agilent Technologies Revenue
Agilent Technologies had revenue of $1.74B in the quarter ending July 31, 2025, with 10.14% growth. This brings the company's revenue in the last twelve months to $6.79B, up 4.48% year-over-year. In the fiscal year ending October 31, 2024, Agilent Technologies had annual revenue of $6.51B, down -4.73%.
Revenue (ttm)
$6.79B
Revenue Growth
+4.48%
P/S Ratio
6.34
Revenue / Employee
$379,218
Employees
17,900
Market Cap
42.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2024 | 6.51B | -323.00M | -4.73% |
| Oct 31, 2023 | 6.83B | -15.00M | -0.22% |
| Oct 31, 2022 | 6.85B | 529.00M | 8.37% |
| Oct 31, 2021 | 6.32B | 980.00M | 18.36% |
| Oct 31, 2020 | 5.34B | 176.00M | 3.41% |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
A News
- 3 days ago - Agilent Announces Cash Dividend of 25.5 Cents Per Share - Business Wire
- 4 days ago - Agilent to Participate in Citi's 2025 Global Healthcare Conference - Business Wire
- 10 days ago - Agilent Research Catalyst (ARC) Award Presented to UC Davis for Breakthroughs in Peptide Therapeutics - Business Wire
- 23 days ago - Agilent to Announce Fourth-Quarter Fiscal Year 2025 Financial Results on Nov. 24 - Business Wire
- 26 days ago - Agilent Names Adam S. Elinoff as Chief Financial Officer - Business Wire
- 7 weeks ago - Agilent Announces New Insight Series Alarm Resolution Systems for Airport Security Screening - Business Wire
- 7 weeks ago - Agilent Introduces the Altura Line of Inert HPLC Columns for Superior Results in Biotherapeutic Testing - Business Wire
- 2 months ago - Agilent Technologies, Inc. (A) gilent Technologies, Inc. Presents at Bank of merica Global Healthcare Conference 2025 Transcript - Seeking Alpha